Stockreport

Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors

Turn Therapeutics Inc.  (TTRX) 
PDF LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immun [Read more]